Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Songnian Lin

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Nature Communications|January 23, 2024
Author Correction: Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonistsMargaret Wu, Ester Carballo-Jane, Haihong Zhou, et al.
Journal of Lipid Research|September 17, 2015
Glucagon receptor antagonism induces increased cholesterol absorptionHong-Ping Guan, Xiaodong Yang, Ku Lu, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Nature Communications|February 13, 2025
Author Correction: Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonistsArun Chandramohan, Hubert Josien, Tsz Ying Yuen, et al.
Nature Communications|January 12, 2024
Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonistsArun Chandramohan, Hubert Josien, Tsz Ying Yuen, et al.
Journal of Medicinal Chemistry|March 17, 2022
Discovery of Insulin Receptor Partial Agonists MK-5160 and MK-1092 as Novel Basal Insulins with Potential to Improve Therapeutic IndexDmitri A Pissarnitski, Ahmet Kekec, Lin Yan, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nature Communications|January 23, 2024
Author Correction: Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonistsMargaret Wu, Ester Carballo-Jane, Haihong Zhou, et al.
Journal of Lipid Research|September 17, 2015
Glucagon receptor antagonism induces increased cholesterol absorptionHong-Ping Guan, Xiaodong Yang, Ku Lu, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Nature Communications|February 13, 2025
Author Correction: Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonistsArun Chandramohan, Hubert Josien, Tsz Ying Yuen, et al.
Nature Communications|January 12, 2024
Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonistsArun Chandramohan, Hubert Josien, Tsz Ying Yuen, et al.
Journal of Medicinal Chemistry|March 17, 2022
Discovery of Insulin Receptor Partial Agonists MK-5160 and MK-1092 as Novel Basal Insulins with Potential to Improve Therapeutic IndexDmitri A Pissarnitski, Ahmet Kekec, Lin Yan, et al.
Pageof 4